English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Zynex
Patient Daily
| May 18, 2023
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily
| May 18, 2023
Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily
| May 18, 2023
Zynex Announces Update Regarding Previously Announced Offerings
Patient Daily
| May 18, 2023
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
Patient Daily
| Apr 24, 2023
Zynex, Inc. to Announce First Quarter 2023 Financial Results
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
